Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 14.70
Day High 15.31
Open:14.82
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
PR Newswire - Thu Sep 20, 1:02PM CDT
PR Newswire - CMTX
Thu Sep 20, 1:02PM CDT
Array BioPharma Inc. (NASDAQ: ARRY) today announced that the European Commission (EC) has approved BRAFTOVI® in combination with MEKTOVI® for the treatment of adult patients with unresectable or metastatic melanoma with a BRAFV600 mutation, as detected by a validated test. This approval is applicable to all 28 European Union (EU) member states, as well as Liechtenstein, Iceland and Norway.
Watch for Array Biopharma to Potentially Pullback After Gaining 7.65% Yesterday
Comtex SmarTrend(R) - Tue Sep 18, 1:03PM CDT
Comtex SmarTrend(R) - CMTX
Tue Sep 18, 1:03PM CDT
Array Biopharma (NASDAQ:ARRY) traded in a range yesterday that spanned from a low of $13.98 to a high of $14.89. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high of $14.21 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Today's Research Reports on Trending Tickers: Array BioPharma and Intercept Pharmaceuticals
ACCESSWIRE - Wed Aug 22, 7:02AM CDT
ACCESSWIRE - CMTX
Wed Aug 22, 7:02AM CDT
NEW YORK, NY / ACCESSWIRE / August 22, 2018 / U.S. markets continue to edge higher on Tuesday as optimism over trade talks and upbeat earnings pushed equities into the green. Additionally, the Federal Reserve will release details on the latest meeting on Wednesday. On Friday, Fed Chairman Jerome Powell is scheduled for a speech at the Kansas City Fed's annual summer retreat. The Dow Jones Industrial Average hiked 0.25 percent to close at 25,822.29, while the S&P 500 Index have gained 0.21 percent to close at 2,862.96. The Nasdaq Composite Index increased 0.49 percent to close at 7,859.17.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 13.56 +12.82% increase
on 09/14/18
Period Open:13.86
Price movement based on the high, low and last over the given period.
15.71 -2.61% decrease
on 08/30/18
+1.44 (+10.39%) increase
since 08/21/18
3-Month 13.31 +14.95% increase
on 08/20/18
Period Open:19.55
Price movement based on the high, low and last over the given period.
19.88 -23.04% decrease
on 06/22/18
-4.25 (-21.74%) decrease
since 06/21/18
52-Week 9.98 +53.31% increase
on 10/27/17
Period Open:11.47
Price movement based on the high, low and last over the given period.
20.21 -24.29% decrease
on 06/21/18
+3.83 (+33.39%) increase
since 09/21/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement